Ryan Zimmerman
Stock Analyst at BTIG
(4.67)
# 195
Out of 4,749 analysts
171
Total ratings
62.76%
Success rate
19.18%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $87 → $91 | $93.12 | -2.28% | 11 | Dec 12, 2024 | |
| VCEL Vericel | Maintains: Buy | $56 → $66 | $59.25 | +11.39% | 8 | Nov 26, 2024 | |
| PEN Penumbra | Maintains: Buy | $232 → $270 | $269.00 | +0.37% | 16 | Nov 26, 2024 | |
| GKOS Glaukos | Maintains: Buy | $140 → $149 | $157.75 | -5.55% | 10 | Nov 26, 2024 | |
| ISRG Intuitive Surgical | Maintains: Buy | $535 → $561 | $580.18 | -3.31% | 17 | Nov 26, 2024 | |
| SYK Stryker | Maintains: Buy | $383 → $394 | $390.43 | +0.91% | 15 | Oct 30, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $4.72 | +111.86% | 4 | Oct 18, 2024 | |
| ALC Alcon | Maintains: Buy | $104 → $106 | $92.32 | +14.82% | 11 | Oct 14, 2024 | |
| IART Integra LifeSciences Holdings | Upgrades: Neutral | n/a | $26.34 | - | 6 | Oct 7, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Buy | $134 → $126 | $110.62 | +13.90% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $89.55 | +11.67% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $75.30 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $32.86 | +122.15% | 4 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $23.97 | +121.11% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.53 | +463.49% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $10.03 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $9.47 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.83 | +118.58% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.77 | +59.15% | 6 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.50 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $59 → $52 | $24.14 | +115.41% | 7 | Oct 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.65 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $17.96 | +55.90% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $181.70 | +10.07% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $280.03 | +24.99% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $130 | $128.81 | +0.92% | 3 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $71.57 | - | 1 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $91.99 | +39.15% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $10.83 | +38.50% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $72.17 | +26.09% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $19.88 | +111.27% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $15.71 | +234.18% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.27 | - | 3 | Apr 2, 2020 |
Globus Medical
Dec 12, 2024
Maintains: Buy
Price Target: $87 → $91
Current: $93.12
Upside: -2.28%
Vericel
Nov 26, 2024
Maintains: Buy
Price Target: $56 → $66
Current: $59.25
Upside: +11.39%
Penumbra
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $269.00
Upside: +0.37%
Glaukos
Nov 26, 2024
Maintains: Buy
Price Target: $140 → $149
Current: $157.75
Upside: -5.55%
Intuitive Surgical
Nov 26, 2024
Maintains: Buy
Price Target: $535 → $561
Current: $580.18
Upside: -3.31%
Stryker
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $390.43
Upside: +0.91%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $4.72
Upside: +111.86%
Alcon
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $92.32
Upside: +14.82%
Integra LifeSciences Holdings
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $26.34
Upside: -
Zimmer Biomet Holdings
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $110.62
Upside: +13.90%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $89.55
Upside: +11.67%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $75.30
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $72 → $73
Current: $32.86
Upside: +122.15%
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $23.97
Upside: +121.11%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.53
Upside: +463.49%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $10.03
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $9.47
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $1.83
Upside: +118.58%
Dec 27, 2023
Maintains: Buy
Price Target: $4 → $6
Current: $3.77
Upside: +59.15%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.50
Upside: -
Oct 4, 2023
Maintains: Buy
Price Target: $59 → $52
Current: $24.14
Upside: +115.41%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $18.65
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $17.96
Upside: +55.90%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $181.70
Upside: +10.07%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $280.03
Upside: +24.99%
Apr 17, 2023
Maintains: Buy
Price Target: $125 → $130
Current: $128.81
Upside: +0.92%
Oct 31, 2022
Initiates: Neutral
Price Target: n/a
Current: $71.57
Upside: -
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $91.99
Upside: +39.15%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $10.83
Upside: +38.50%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $72.17
Upside: +26.09%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $19.88
Upside: +111.27%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $15.71
Upside: +234.18%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $18.27
Upside: -